Vaccines against malaria-still a long way to go. (Q34556687)

3 August 2017

1 reference

title

Vaccines against malaria-still a long way to go. (English)

1 reference

3 August 2017

0 references

1 reference

Kai Matuschewski

1

0 references

language of work or name

English

0 references

publication date

13 May 2017

1 reference

3 August 2017

1 reference

3 August 2017

Malaria - an overview

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

The origins of malaria: there are more things in heaven and earth …

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Cell biology and immunology of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Immunity to malaria: more questions than answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

On natural and artificial vaccinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Immune evasion by malaria parasites: a challenge for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Malaria Parasites: The Great Escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Immune mechanisms in malaria: new insights in vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Murine infection models for vaccine development: the malaria example

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Experimental human challenge infections can accelerate clinical malaria vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

A research agenda for malaria eradication: vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Advances and challenges in malaria vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

The path of malaria vaccine development: challenges and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Vaccine development against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Vaccines against malaria - an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Plasmodium Sporozoite Biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Antibody and B cell responses to Plasmodium sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

The Plasmodium sporozoite survives RTS,S vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Targeting Plasmodium liver stages: better late than never

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Genetically modified Plasmodium parasites as a protective experimental malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Natural immunization against malaria: causal prophylaxis with antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Identification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Liver-Resident Memory CD8+ T Cells Form a Front-Line Defense against Malaria Liver-Stage Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Functional Antibodies and Protection against Blood-stage Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

The cellular and molecular basis for malaria parasite invasion of the human red blood cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Young lives lost as B cells falter: what we are learning about antibody responses in malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Why do some African children develop severe malaria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Development of malaria transmission-blocking vaccines: from concept to product

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Immunological mechanisms of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Designing a VAR2CSA-based vaccine to prevent placental malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

From the circumsporozoite protein to the RTS, S/AS candidate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Human hepatitis B vaccine from recombinant yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Adjuvant system AS01: helping to overcome the challenges of modern vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

A recombinant Bacille Calmette-Guérin construct expressing the Plasmodium falciparum circumsporozoite protein enhances dendritic cell activation and primes for circumsporozoite-specific memory cells in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Protective immunity against malaria by 'natural immunization': a question of dose, parasite diversity, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.14107

21 January 2018

Identifiers

DOI

10.1111/FEBS.14107

1 reference

3 August 2017

1 reference

PubMed ID

28500775